A innovative medication, the drug , is sparking significant buzz within the medical community as a possible treatment for weight challenges. Developed by the company , it’s a double GIP and GLP-1 receptor agonist, meaning it works on two separate pathways to regulate hunger and promote metabolic expenditure . Early clinical results have demonstra